Experimental study on peritoneal dialysis using xylitol-containing solution
Yen, T.S.
Journal of the Formosan Medical Association 69(6): 292-304
1970
ISSN/ISBN: 0371-7682 PMID: 5273020 Document Number: 21373
Document emailed within 1 workday
Related Documents
Jakić, M.; Stipanić, S.; Mihaljević, D.; Zibar, L.; Lovcić, V.; Klarić, D.; Jakić, M. 2005: The impact of glucose absorbed from dialysis solution on body weight gain in peritoneal dialysis treated patients Lijecnicki Vjesnik 127(5-6): 116-120Opatrná, S.; Racek, J.; Stehlík, P.; Senft, V.; Sefrna, F.; Topolcan, O.; Opatrný, K. 2002: Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis Casopis Lekaru Ceskych 141(9): 281-285
Günal, A.I.; Celiker, H.; Ustundag, B.; Akpolat, N.; Dogukan, A.; Akcicek, F. 2003: The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution Journal of Nephrology 16(2): 225-230
Khandelwal, M.; Oreopoulos, D.G. 2004: Is there a need for low sodium dialysis solution for peritoneal dialysis patients? Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 20: 156-162
Okada, E.; Oishi, D.; Sakurada, T.; Yasuda, T.; Shibagaki, Y. 2015: A Comparison Study of Glucose Fluctuation During Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 31: 34-37
Higashi, H.; Ehira, T.; Kobayashi, T.; Shimoji, K.; Hirayama, K. 1972: Treatment of acute bromvalerylurea (Brovalin) poisoning by peritoneal dialysis--analysis of bromvalerylurea in the dialysis solution Masui. Japanese Journal of Anesthesiology 21(1): 81-86
Garosi, G.; Di Paolo, N. 2000: Pathophysiology and morphological clinical correlation in experimental and peritoneal dialysis-induced peritoneal sclerosis Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 16: 204-207
Mawhinney, W.M.; Adair, C.G.; Gorman, S.P.; McClurg, B. 1992: Stability of ciprofloxacin in peritoneal dialysis solution American Journal of Hospital Pharmacy 49(12): 2956-2959
Cueto-Manzano, A.M.; Rojas-Campos, E.; Martínez-Ramírez, H.éc.R.; Valera-González, I.; Medina, M.; Monteón, F.; Ruiz, N.; Becerra, M.; Palomeque, M.A.; Cortés-Sanabria, L. 2006: Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis? Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(3): 341-348
Nishimura, H.; Ikehara, O.; Naito, T.; Higuchi, C.; Sanaka, T. 2009: Evaluation of taurine as an osmotic agent for peritoneal dialysis solution Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 29(2): 204-216
Cara, M.; Virga, G.; Mastrosimone, S.; Girotto, A.; Rossi, V.; D'Angelo, A.; Bonfante, L. 2005: Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution Journal of Nephrology 18(1): 67-71
Blake, P.G.; Golper, T.A.; Saxena, A.B. 2014: A critical shortage of solution threatens unprecedented growth in peritoneal dialysis Nephrology News and Issues 28(12): 14-16
La Milia, V. 2011: Peritoneal dialysis solution recall because of endotoxin contamination: from emergency to opportunity Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 28(2): 121-123
Neilan, G.E.; Kennedy, T.L. 1984: Simplified method of preparing lactate-free peritoneal-dialysis solution American Journal of Hospital Pharmacy 41(10): 1994; 1996
Passlick-Deetjen, J.; Pischetsrieder, M.; Witowski, J.; Bender, T.O.; Jörres, A.; Lage, C. 2001: In vitro superiority of dual-chambered peritoneal dialysis solution with possible clinical benefits Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 21(Suppl 3): S96-101
Van Biesen, W.; Boer, W.; De Greve, B.; Dequidt, C.; Vijt, D.; Faict, D.; Lameire, N. 2004: A randomized clinical trial with a 0.6% amino acid/ 1.4% glycerol peritoneal dialysis solution Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 24(3): 222-230
Kumano, K.; Kawaguchi, Y. 2000: Multicenter cross-sectional study for dialysis dose and physician's subjective judgment in Japanese peritoneal dialysis patients. Group for the Water and Electrocyte Balance Study in CAPD American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 35(3): 515-525
Vande Walle, J.; Raes, A.; Dehoorne, J.; Mauel, R.; Dejaeghere, A.; Matthys, D. 2004: Combined amino-acid and glucose peritoneal dialysis solution for children with acute renal failure Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 20: 226-230
Arfeen, S.; Goodship, T.H.; Kirkwood, A.; Ward, M.K. 1990: The nutritional/metabolic and hormonal effects of 8 weeks of continuous ambulatory peritoneal dialysis with a 1% amino acid solution Clinical Nephrology 33(4): 192-199
Pietrzak, I.; Baczyk, K.; Ksiazek, P. 1995: Thiamine blood level and erythrocyte transketolase activity in continuous ambulatory peritoneal dialysis and intermittent peritoneal dialysis patients Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 50: 197-203